Company Filing History:
Years Active: 2013
Title: Lassina Badolo: Innovator in Schizophrenia Treatment
Introduction
Lassina Badolo is a notable inventor based in Kobenhavn NV, Denmark. He has made significant contributions to the field of pharmacology, particularly in the treatment of schizophrenia. His innovative work focuses on developing compounds that target specific receptors in the central nervous system.
Latest Patents
Lassina Badolo holds a patent for "Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia." This invention relates to deuterated 1-piperazino-3-phenyl-indanes and their salts, which exhibit activity at dopamine receptors D and D as well as the 5HT receptors in the central nervous system. The patent outlines the use of these compounds as active ingredients in medicaments for treating diseases of the central nervous system, along with methods of treatment involving their administration. He has 1 patent to his name.
Career Highlights
Lassina Badolo is currently employed at H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to contribute to the development of innovative treatments that address complex neurological conditions.
Collaborations
Throughout his career, Lassina has collaborated with esteemed colleagues, including Morten Jorgensen and Peter Hongaard Andersen. These collaborations have fostered a productive environment for research and development in the field of mental health.
Conclusion
Lassina Badolo is a pioneering inventor whose work in the treatment of schizophrenia has the potential to make a significant impact on the lives of those affected by this condition. His dedication to innovation in pharmacology continues to drive advancements in mental health treatment.